The likelihood of a high-performing drug launch is approximately one in three, meaning that two-thirds of drug launches fall short of expectations. Capturing the full …
Immunotherapy is currently one of the hottest areas in the pharma industry, and development of new targets continues apace. Already, several novel therapeutics have recently …
Among the major functions of a life science company’s pharmacovigilance (PV) department, case management is one of the most resource-intensive processes, involving considerable manual activities. …
A recent paper has shown that macromolecules can pass rapidly from the nose into the brain along olfactory nerves, and into the brain and brain …
Respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) remain the third leading cause of death globally and are growing in prevalence throughout the …
Once considered a DNA co-purifying annoyance, histone proteins have proven to be an essential component of our genomic makeup. Post-translational modification (PTM) to these proteins …
Investigational Drifts and Technology Synergy Driving Major Opportunities Gene and cell therapies gained industry interest about two decades ago. Since then, a number of therapies …
The burgeoning field of biosimilars provides opportunities for biopharma and biotech companies to bring lower-cost products to the marketplace more rapidly than is possible for novel …
Technology and advanced analytics in clinical research is an extremely broad topic and its development is accelerating. Within the clinical research environment, late-phase research (Phases …
Phase IIIa trials represent the final stage in determining whether a drug or medical device can make it to market. These trials normally operate at …
The European Parliament adopted proposals for two new EU Regulations on medical devices on 5 April 2017 – one for medical devices and the other …
This is always a very difficult question to answer. There are reasons to file an application as early as possible and there are competing reasons …
The biophysical characterisation of biopharmaceuticals is critical to the development of a well-controlled large-scale production process. Moreover, as patents expire, the number of biosimilar candidates …
Genome editing is not a ‘new’ technology. Genome editing has been around for somewhere between 25 to 30 years. This technology, while forming the foundation …
Analytics is the discovery, interpretation, and communication of meaningful patterns and knowledge in recorded data. In the life sciences, analytics are crucial for understanding the …
HORIBA Scientific’s unique Surface Plasmon Resonance imaging (SPRi) instrument enables a large number of different label-free molecular interactions to be monitored simultaneously and in parallel …
The pharmaceutical supply chain is in a state of disruption. Drugs intended to help, heal, and save are being compromised every day – and the …
